Trial data does not show whether adding Cablivi to standard care improves either length or quality of life over the long term, the Institute said More: NICE rejects Sanofi's Cablivi in draft guidelines Source: News
read moreThe move comes as cancer services face a huge backlog of patients whose treatment has been on pause during the coronavirus pandemic More: NHS accelerates launch of new radiotherapy Source: News
read moreAstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine kblankenship Thu, 06/11/2020 – 14:49 More: AstraZeneca, Emergent BioSolutions sign M deal to produce U.S. supply of COVID-19 vaccine Source: fierce
read moreBIO: ‘Boom and bust’ pandemic response isn’t working, Sanofi exec says. It’s time to get ready for future outbreaks esagonowsky Thu, 06/11/2020 – 12:05 More: BIO: 'Boom and bust' pandemic response isn't working, Sanofi exec says. It's time to get
read moreFiercePharmaAsia—Roche-Innovent deal; Lilly-Junshi COVID pact; Fujifilm, WuXi Biologics expansions aliu Thu, 06/11/2020 – 10:53 More: FiercePharmaAsia—Roche-Innovent deal; Lilly-Junshi COVID pact; Fujifilm, WuXi Biologics expansions Source: fierce
read moreTakeda, debt in mind, offloads 18 drugs in Asia Pacific to Celltrion for $278M aliu Thu, 06/11/2020 – 10:29 More: Takeda, debt in mind, offloads 18 drugs in Asia Pacific to Celltrion for 8M Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals